Top Enrolling Site Globally for a Phase 2 Rare Hepatology and Gastroenterology Trial 

Science 37 was the top enrolling site globally in a multinational clinical trial spanning North America, Europe, Latin America, and Asia-Pacific. Brought in to revitalize recruitment efforts and boost patient randomization, Science 37 played a pivotal role in re-engaging the rare PSC community, raising awareness, and helping to put the study timeline back on track.